PARIS — The tight collaboration between industry and medical professionals is most often the subject of derision, scrutiny and sometimes lawsuits. A report of conflicts of interest with companies is the first slide in presentations by any clinician at a conference and are routinely noted in published articles.

The colonoscope is the primary tool gastroenterologists rely on to screen patients for colorectal cancer and colonoscopy exams are still considered the most sensitive method for detecting cancers. But too many adenomas, or precancerous polyps, are missed during colonoscopy because they can hide on the backside of the colon folds. This week at Digestive Disease Week (DDW) in Orlando, Florida, EndoChoice (Alpharetta, Georgia) unveiled research showing that its new FUSE (Full Spectrum Endoscope) system significantly improves the accuracy of the procedure and greatly reduces the number of adenomas missed by colonoscopists.